Annual CAPEX
N/A
31 December 2022
Summary:
Nymox Pharmaceutical annual capital expenditures is not available.NYMX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
31 March 2023
Summary:
Nymox Pharmaceutical quarterly capital expenditures is not available.NYMX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
31 March 2023
Summary:
Nymox Pharmaceutical TTM capital expenditures is not available.NYMX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NYMX CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
NYMX CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time |
Nymox Pharmaceutical CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | $4000.00(>+9900.0%) | $6000.00(-57.1%) |
| Sept 2021 | - | $0.00(0.0%) | $14.00 K(-6.7%) |
| June 2021 | - | $0.00(-100.0%) | $15.00 K(0.0%) |
| Mar 2021 | - | $2000.00(-83.3%) | $15.00 K(+15.4%) |
| Dec 2020 | $13.00 K(-63.9%) | $12.00 K(+1100.0%) | $13.00 K(+1200.0%) |
| Sept 2020 | - | $1000.00(-96.0%) | $1000.00(-97.2%) |
| Dec 2018 | $36.00 K(+1700.0%) | $25.00 K(+127.3%) | $36.00 K(+227.3%) |
| Sept 2018 | - | $11.00 K(>+9900.0%) | $11.00 K(+205.6%) |
| Dec 2016 | $2000.00(-42.9%) | - | - |
| Dec 2014 | $3500.00(-46.2%) | $0.00(-100.0%) | $3600.00(-26.5%) |
| Sept 2014 | - | $1500.00(>+9900.0%) | $4900.00(-31.9%) |
| June 2014 | - | $0.00(-100.0%) | $7200.00(0.0%) |
| Mar 2014 | - | $2100.00(+61.5%) | $7200.00(+10.8%) |
| Dec 2013 | $6500.00(+91.2%) | $1300.00(-65.8%) | $6500.00(+25.0%) |
| Sept 2013 | - | $3800.00(>+9900.0%) | $5200.00(+52.9%) |
| June 2013 | - | $0.00(-100.0%) | $3400.00(-10.5%) |
| Mar 2013 | - | $1400.00(>+9900.0%) | $3800.00(+11.8%) |
| Dec 2012 | $3400.00(-84.6%) | $0.00(-100.0%) | $3400.00(-41.4%) |
| Sept 2012 | - | $2000.00(+400.0%) | $5800.00(-3.3%) |
| June 2012 | - | $400.00(-60.0%) | $6000.00(-53.5%) |
| Mar 2012 | - | $1000.00(-58.3%) | $12.90 K(-41.9%) |
| Dec 2011 | $22.10 K(+151.1%) | $2400.00(+9.1%) | $22.20 K(+7.8%) |
| Sept 2011 | - | $2200.00(-69.9%) | $20.60 K(+9.0%) |
| June 2011 | - | $7300.00(-29.1%) | $18.90 K(+50.0%) |
| Mar 2011 | - | $10.30 K(+1187.5%) | $12.60 K(+43.2%) |
| Dec 2010 | $8800.00(+300.0%) | $800.00(+60.0%) | $8800.00(+10.0%) |
| Sept 2010 | - | $500.00(-50.0%) | $8000.00(-14.0%) |
| June 2010 | - | $1000.00(-84.6%) | $9300.00(+6.9%) |
| Mar 2010 | - | $6500.00(>+9900.0%) | $8700.00(+295.5%) |
| Dec 2009 | $2200.00(-81.4%) | $0.00(-100.0%) | $2200.00(-101.8%) |
| Sept 2009 | - | $1800.00(+350.0%) | -$125.10 K(+59.8%) |
| June 2009 | - | $400.00(-100.3%) | -$78.30 K(-763.6%) |
| Dec 2008 | $11.80 K(-99.0%) | -$127.30 K(-361.9%) | $11.80 K(-97.4%) |
| Sept 2008 | - | $48.60 K(-46.3%) | $461.20 K(-13.1%) |
| June 2008 | - | $90.50 K(-71.9%) | $530.80 K(-55.4%) |
| Dec 2007 | $1.19 M | $322.10 K(+172.5%) | $1.19 M(+23.0%) |
| Sept 2007 | - | $118.20 K(-66.9%) | $966.80 K(+9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2007 | - | $357.10 K(-8.8%) | $883.60 K(+22.7%) |
| Mar 2007 | - | $391.70 K(+292.5%) | $719.90 K(+93.1%) |
| Dec 2006 | $373.00 K(-34.1%) | $99.80 K(+185.1%) | $372.90 K(+24.8%) |
| Sept 2006 | - | $35.00 K(-81.9%) | $298.90 K(-2.6%) |
| June 2006 | - | $193.40 K(+332.7%) | $306.90 K(-35.4%) |
| Mar 2006 | - | $44.70 K(+73.3%) | $475.10 K(-16.0%) |
| Dec 2005 | $565.80 K(+39.4%) | $25.80 K(-40.0%) | $565.80 K(+52.4%) |
| Sept 2005 | - | $43.00 K(-88.1%) | $371.20 K(-22.1%) |
| June 2005 | - | $361.60 K(+167.1%) | $476.70 K(+49.5%) |
| Mar 2005 | - | $135.40 K(-180.2%) | $318.90 K(-21.5%) |
| Dec 2004 | $406.00 K(+37.7%) | -$168.80 K(-213.7%) | $406.00 K(-41.3%) |
| Sept 2004 | - | $148.50 K(-27.1%) | $691.70 K(+7.6%) |
| June 2004 | - | $203.80 K(-8.4%) | $642.60 K(+29.0%) |
| Mar 2004 | - | $222.50 K(+90.3%) | $498.30 K(+69.0%) |
| Dec 2003 | $294.90 K(+2186.0%) | $116.90 K(+17.6%) | $294.90 K(-383.0%) |
| Sept 2003 | - | $99.40 K(+67.1%) | -$104.20 K(+73.4%) |
| June 2003 | - | $59.50 K(+211.5%) | -$60.10 K(-8.8%) |
| Mar 2003 | - | $19.10 K(-106.8%) | -$65.90 K(-610.9%) |
| Dec 2002 | $12.90 K(-96.2%) | -$282.20 K(-296.7%) | $12.90 K(-96.9%) |
| Sept 2002 | - | $143.50 K(+167.2%) | $413.20 K(+20.4%) |
| June 2002 | - | $53.70 K(-45.1%) | $343.20 K(-10.6%) |
| Mar 2002 | - | $97.90 K(-17.1%) | $383.80 K(+12.7%) |
| Dec 2001 | $340.70 K(-10.7%) | $118.10 K(+60.7%) | $340.60 K(+0.4%) |
| Sept 2001 | - | $73.50 K(-22.1%) | $339.20 K(-7.2%) |
| June 2001 | - | $94.30 K(+72.4%) | $365.40 K(-3.7%) |
| Mar 2001 | - | $54.70 K(-53.1%) | $379.30 K(-0.6%) |
| Dec 2000 | $381.60 K(+131.6%) | $116.70 K(+17.1%) | $381.60 K(+15.7%) |
| Sept 2000 | - | $99.70 K(-7.9%) | $329.80 K(-0.1%) |
| June 2000 | - | $108.20 K(+89.8%) | $330.00 K(+48.8%) |
| Mar 2000 | - | $57.00 K(-12.2%) | $221.80 K(+34.6%) |
| Dec 1999 | $164.80 K(-57.8%) | $64.90 K(-35.0%) | $164.80 K(-43.1%) |
| Sept 1999 | - | $99.90 K(-47.3%) | $289.50 K(-25.8%) |
| Dec 1998 | $390.10 K(+95.2%) | $189.60 K(>+9900.0%) | $390.10 K(+94.6%) |
| Sept 1998 | - | $400.00(-99.6%) | $200.50 K(+0.2%) |
| June 1998 | - | $100.20 K(+0.3%) | $200.10 K(+100.3%) |
| Mar 1998 | - | $99.90 K | $99.90 K |
| Dec 1997 | $199.80 K | - | - |
FAQ
- What is the all time high annual CAPEX for Nymox Pharmaceutical?
- What is the all time high quarterly CAPEX for Nymox Pharmaceutical?
- What is the all time high TTM CAPEX for Nymox Pharmaceutical?
What is the all time high annual CAPEX for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high annual capital expenditures is $1.19 M
What is the all time high quarterly CAPEX for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high quarterly capital expenditures is $391.70 K
What is the all time high TTM CAPEX for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high TTM capital expenditures is $1.19 M